Future-proofing institutional IT

Changing the way patients are diagnosed and treated

Intuitive, painless, integrated clinical decision support for use in and out of tumor board meetings, on site and remote.

Future-proofing institutional IT

Changing the way patients are diagnosed and treated

Intuitive, painless, integrated clinical decision support for use in and out of tumor board meetings, on site and remote.

An opportunity for healthcare IT

Precision oncology — a diverse set of strategies in cancer care personalized for the biology of an individual patient’s disease — is emerging, with application in 70% of US and European oncology practices.1

However, with only 14% of oncologists routinely participating in molecular tumor boards, 18% regularly using clinical decision support (CDS) tools and 41% frequently deploying targeted therapies according to a patient’s genomic alteration,1 the growth of precision oncology depends on the development of innovative IT.

An open platform to the future

navify Decision Support portfolio operates from an open platform for software developed by Roche, partners and third parties to maximize functionality and actionable, data-driven insights.

Through navify portfolio and the ever-expanding navify Clinical Decision Support apps ecosystem, institutions may subscribe to the workflows and integrated apps that drive the efficiency, accuracy and clinician satisfaction achievements at the core of their missions.

System interoperability

The benefits offered by an integration and implementation of navify Tumor Board to provide all available patient data extend beyond multidisciplinary team collaboration and diagnostics processing. navify workflows enhanced by CDS apps are ready to support insights from clinical trials, scientific exploration and medical advances.

NAVIFY® Infographic about what oncologists expect from CDS tools

Changing needs and budgets

navify portfolio allows organizations to implement what they need today with the agility and solutions to serve their needs tomorrow.

With its foundation in the cloud, navify Software as a Service products meet common changes to budgets as well.

Top opportunity for cost savings: 40-50% reduction in labor costs associated with case preparation and case discussion time.2

Explore
more

Still image from video discussing the value of NAVIFY Tumor Board

Value-mapping tumor boards

Play video

Partial cover of NAVIFY® Tumor Board Case Study: Data integration gives specialists more time with patients

Case study: Data integration gives more time for patients

Read more

An image of two lab technicians at work

navify Mutation Profiler*

Read more

  1. Dupuy, F. and Ohnmacht, F. (2020) ‘The Future Is Now: How to Drive Precision Oncology Adoption’, Accenture Life Sciences.
  2. Data on file.

* Research Use Only in the United States. Not for use in diagnostic procedures.

Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050

© 2023 Roche Molecular Systems, Inc.
NAVIFY is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.

Not all products of this product portfolio are intended or approved for diagnostic use. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

×

You will be redirected to another site. Do you want to continue?

OK